We found that intermittent short-duration reoxygenation relieved pulmonary hypertension via NOX4/H2O2/PPAR-γ axis and further reducing non-NOX4 dereived H2O2 could further alleviated hypoxic pulmonary hypertension. The gene discussed is NOX4; the disease is pulmonary arterial hypertension.